Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of OVID will rise by +8.12% over the next 2 Weeks and hit $2.99 by Thursday, May 14, 2026. In that time frame, OVID's share price is expected to range between $2.78 and $3.23.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| May 14, 2026 | 2.88 | 3.11 | 3.34 |
| May 13, 2026 | 2.81 | 3.05 | 3.29 |
| May 12, 2026 | 2.88 | 3.10 | 3.32 |
| May 11, 2026 | 2.83 | 3.04 | 3.27 |
| May 8, 2026 | 2.90 | 3.14 | 3.37 |
| May 7, 2026 | 2.77 | 3.00 | 3.24 |
| May 6, 2026 | 2.71 | 2.94 | 3.17 |
| May 5, 2026 | 2.74 | 2.98 | 3.21 |
| May 4, 2026 | 2.72 | 2.93 | 3.18 |
| May 1, 2026 | 2.80 | 3.02 | 3.25 |
OVID shares rose +5.56% in Monday, May 4, 2026's trading session, rising from a previous close of $2.79 to move at $2.95. The stock demonstrated notable intraday movement (see OVID's key stats for a full breakdown), fluctuating between $2.75 and $2.97, a +8.00% trading range. While recent weeks have seen some volatility, OVID has managed to secure a +5.18% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 1.31M shares changing hands, 66.82K fewer than the previous session. This amounted to $3.86M in total market activity.
Will OVID Continue Its Upward Trend?
According to analyst ratings and projections for OVID, Ovid Therapeutics Inc. shares are anticipated to increase by +11.89%, potentially reaching $3.34 per share by May 14, 2026. Short-term technical indicators currently suggest a neutral sentiment for OVID. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 16 positive trading days within the past 30 sessions. Based on the OVID stock forecast, now is a good time to buy OVID stock because its current trading price is -5.34% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on OVID covering social and institutional perspectives.
OVID Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into OVID's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 63.39% to 67.70%) suggest the stock is in a bullish momentum phase. The 50-day RSI, at 60.73%, suggests strong medium-term momentum. Additionally, the 100-day RSI, at 58.67%, maintains a neutral outlook for the long term. Insights into OVID's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Ovid Therapeutics Short-Term Forecasts
OVID Forecast For Next 5 Days
Our algorithm anticipates Ovid Therapeutics (OVID) stock could hit $2.68 by May 11, 2026. This represents a -8.94% fall from today's price, following a -5.59% change over the past five days.
OVID Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Ovid Therapeutics Inc. (OVID) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $2.78, which would mean a -5.60% decrease from the current price of $2.95. Projections for this period range from a high of $3.21 to a low of $2.24.
OVID Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Ovid Therapeutics's price over the next three months point to a rise. OVID stock is expected to peak at $23.66 on Jun 05, 2026 before potentially dipping to $15.73 on Jul 09, 2026. On average, OVID is likely to trade around $19.35 in the coming 90 days.
Ovid Therapeutics Stock Forecast 2025
Based on our predictive models, Ovid Therapeutics (OVID) is expected to trade between $15.73 and $28.20 throughout 2026. This would result in an average price of $20.54, potentially offering investors a +597.45% return from current levels.
Ovid Therapeutics Inc. Monthly Forecast 2026–2027
May 2026
According to our latest forecast models, Ovid Therapeutics Inc. (OVID) is positioned to show a strong performance in May 2026. The price is predicted to move between $17.66 and $22.66, settling at an average of $19.82. This could translate to a +573.01% gain.
June 2026
Based on current market signals, Ovid Therapeutics Inc. is projected to trend june 2026. We forecast a trading range from $16.95 to $23.66, with a likely average price of $21.04. Investors could expect a potential return of +614.43%.
July 2026
Our predictive algorithms indicate Ovid Therapeutics Inc. stock may see a shift in July 2026. The expected range spans $15.73–$20.23, with an average target of $17.25. This represents a positive outlook and a possible gain of +485.74%.
August 2026
Analyzing established trends, Ovid Therapeutics Inc. looks set to move in August 2026. Projections place the stock between $20.08 and $25.16, averaging around $22.45. This suggests a +662.31% gain from current levels.
September 2026
Market indicators suggest Ovid Therapeutics Inc. could experience notable changes during September 2026. Prices could fluctuate within $18.75 to $23.80, with a midpoint forecast of $20.58. The stock might deliver a +598.81% gain.
October 2026
Forecasting for October 2026, models estimate that Ovid Therapeutics Inc. may undergo key fluctuations. If trends hold, the stock might trade between $21.56 and $26.98, averaging $23.18. This signals a positive trajectory with potential returns around +687.10%.
November 2026
According to our latest forecast models, Ovid Therapeutics Inc. (OVID) is positioned to show a strong performance in November 2026. The price is predicted to move between $18.57 and $28.20, settling at an average of $21.49. This could translate to a +629.71% gain.
December 2026
Based on current market signals, Ovid Therapeutics Inc. is projected to trend december 2026. We forecast a trading range from $17.36 to $24.56, with a likely average price of $18.76. Investors could expect a potential return of +537.01%.
January 2027
Our predictive algorithms indicate Ovid Therapeutics Inc. stock may see a shift in January 2027. The expected range spans $20.78–$27.69, with an average target of $22.10. This represents a positive outlook and a possible gain of +650.42%.
February 2027
Analyzing established trends, Ovid Therapeutics Inc. looks set to move in February 2027. Projections place the stock between $19.16 and $26.70, averaging around $20.60. This suggests a +599.49% gain from current levels.
March 2027
Market indicators suggest Ovid Therapeutics Inc. could experience notable changes during March 2027. Prices could fluctuate within $20.41 to $33.43, with a midpoint forecast of $22.68. The stock might deliver a +670.12% gain.
April 2027
Forecasting for April 2027, models estimate that Ovid Therapeutics Inc. may undergo key fluctuations. If trends hold, the stock might trade between $26.40 and $35.83, averaging $27.59. This signals a positive trajectory with potential returns around +836.84%.
OVID's history of dividends and stock splits also plays a role in long-term investor confidence.

